Onartuzumab
Encyclopedia
Onartuzumab is a humanized monoclonal antibody designed for the treatment of cancer.
Onartuzumab was developed by Genentech
, Inc.
Onartuzumab was developed by Genentech
Genentech
Genentech Inc., or Genetic Engineering Technology, Inc., is a biotechnology corporation, founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert Boyer. Trailing the founding of Cetus by five years, it was an important step in the evolution of the biotechnology industry...
, Inc.